BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 13, 2008
View Archived Issues
Labopharm reports positive results for phase III trazodone study
Read More
e-STAR data show risperidone long-acting injection beneficial in schizophrenia
Read More
Add-on pimavanserin improves efficacy and safety of risperidone in schizophrenia
Read More
Cervical cancer vaccine safe, immunogenic in stage IB and IIA patients
Read More
Pro-Pharmaceuticals reports encouraging data from phase II trial of Davanat in colorectal cancer
Read More
Blood pressure control safely achieved with clevidipine in high risk patients
Read More
AstraZeneca submits application for Seroquel and Seroquel XR in the E.U.
Read More
Keryx Biopharmaceuticals completes phase III clinical trial of Sulonex
Read More
La Jolla Pharmaceutical presents an update on the phase III trial of Riquent for SLE
Read More
Recent patents impart novel treatment options for cancer
Read More
Washington University investigators study role of moss protein in Alzheimer's disease
Read More
Targanta submits NDA to FDA for oritavancin
Read More
Preliminary clinical data show significant HIV viral load reduction with IDX-899
Read More
Silodosin NDA accepted for filing by FDA for benign prostatic hyperplasia
Read More
Biovitrum completes exploratory phase II study of BVT-28949 in glaucoma
Read More
Positive efficacy data reported from phase II Gabapentin GR trial
Read More
SCH-532706 safe and well tolerated in combination with ritonavir
Read More
Valeant reports positive phase III results for retigabine in RESTORE 1
Read More
Decapeptyl 6-month formulation shows similar efficacy to 3-month triptorelin
Read More
Study shows self-applied diarrhea vaccine patch has robust immune response
Read More
Recent Merck patents describe novel agents for sleep disorders
Read More
Recent Allergan patents disclose new therapeutics for glaucoma
Read More
